The minimal inhibitory concentration (MIC) of Ro 13-9904 against 245 4g/ml).
The minimal inhibitory concentration (MIC) of Ro 13-9904 against 245 clinical isolates was determined by an agar dilution method. The activity of Ro 13-9904 against most Enterobacteriaceae was similar to that of cefotaxime; it was slightly more active than cefotaxime against Proteus mirabilis, Providencia species, and Serratia marcescens, but slightly less active against Klebsiella species. Ro 13-9904 was twofold more active than cefotaxime and threefold more active than ticarcillin against ticarcillin-susceptible Pseudomonas aeruginosa, with a mean MIC of 7.2 ,tg/ml; isolates highly resistant to ticarcillin were inhibited by a mean MIC of 17.2 ,ug/ml. Ro 13-9904 was fourfold more active than ampicillin against susceptible Haemophilus influenzae and was equally active against ,B-lactamaseproducing isolates. Ro 13-9904 was highly active against pneumococci and moderately active (MIC, 4 yg/ml) against Staphylococcus aureus isolates, whether they were susceptible or resistant to penicillin G. Oxacillin-resistant S. aureus and Streptococcus faecalis were completely resistant to Ro 13-9904 (MIC, >128 4g/ml).
combines high antibacterial potency, stability to a wide variety of f8-lactamases, and favorable pharmacokinetic properties (2, 3) . According to the manufacturers (Hoffmann-LaRoche, Inc., Switzerland), Ro 13-9904 has a terminal half-life of 6 to 7 h and a protein binding of 95%. In this study we compared the minimal inhibitory concentrations (MICs) of Ro 13-9904 with those of cephalothin, ampicillin, ticarcillin, and cefotaxime against various penicillin-and cephalothinsusceptible and -resistant isolates. 'ND, not determinable.
MATERIALS AND METHODS
'P. maltophilia (3), P. cepacia (2) , P. putida (2), P.
higher against the strains resistant to cephalothin than against the susceptible ones. 
